Abstract:
The present invention relates to a method for the production of chondroblasts/chondrocytes and furthermore to a method of preparation of chondroblasts/chondrocytes and/or osteoblasts/osteocytes suspensions both especially used for the treatment of cartilage and/or bone defects.
Abstract:
An isolated, acellular biosynthetic cartilaginous matrix substantially devoid of synthetic biodegradable scaffold structure is provided. Through a method with the steps of a) contacting in vitro a population of chondrogenic cells with a synthetic biodegradable scaffold; b) culturing in vitro for a period of time said chondrogenic cells within said synthetic biodegradable scaffold so that the chondrogenic cells produce a biosynthetic cartilaginous matrix; c) substantially removing any antigen derived from said chondrogenic cells a matrix suitable of implantation into a living individual mammal, such as a human being is obtained.
Abstract:
The present invention provides for a method for tissue engineering by cell implantation that involves the use of a scaffold in situ at the site of a defect, where the therapeutic cells are fixed in place into the scaffold only once the scaffold is inserted at the site of the tissue defect, thereby locking not only the cells to the scaffold, but also the scaffold to the tissue defect. The invention also provides a kit of parts suitable for performing the method of the invention.
Abstract:
The present invention relates to a method for the production of chondroblasts/chondrocytes and furthermore to a method of preparation of chondroblasts/chondrocytes and/or osteoblasts/osteocytes suspensions both especially used for the treatment of cartilage and/or bone defects.
Abstract:
The present invention relates to a method for the production of chondroblasts/chondrocytes and furthermore to a method of preparation of chondroblasts/chondrocytes and/or osteoblasts/osteocytes suspensions both especially used for the treatment of cartilage and/or bone defects.